COM(2004)599 EU - Regulation
Medicinal products for paediatric use

Please note

This page contains a limited version of this dossier in the EU Monitor.

Contents

  1. Key information
  2. Key dates
  3. Related information
  4. Resulting legislation
  5. Full version
  6. EU Monitor

1.

Key information

official title

Proposal for a Regulation of the European Parliament and of the Council on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/83/EC and Regulation (EC) No 726/2004
 
Legal instrument Regulation
Decision making procedure ordinary legislative procedure (COD)
reference by COM-number i COM(2004)599 EN
Additional COM-numbers SEC(2004)1144; COM(2005)577; COM(2006)118; COM(2006)408
procedure number i 2004/0217(COD)
CELEX number i 52004PC0599

2.

Key dates

Document 29-09-2004
Online publication 29-09-2004
Decision 12-12-2006; Verordening 2006/1901
Publication in Official Journal i 27-12-2006; Special edition in Croatian: Chapter 13 Volume 064,Special edition in Bulgarian: Chapter 13 Volume 058,OJ L 378, 27.12.2006,Special edition in Romanian: Chapter 13 Volume 058

3.

Related information

4.

Resulting legislation

 

5.

Full version

This page is also available in a full version containing the latest state of affairs, the summary of the European Parliament Legislative Observatory, the legal basis, the legal context, other dossiers related to the dossier at hand, the stakeholders involved (e.g. European Commission directorates-general, European Parliament committees, Council configurations and even individual EU Commissioners and Members of the European Parliament), consultations relevant to the dossier at hand and finally documents of the European Parliament, the Council of Ministers and the European Commission.

The full version is available for registered users of the EU Monitor by ANP and PDC Informatie Architectuur.

6.

EU Monitor

The EU Monitor enables its users to keep track of the European process of lawmaking, focusing on the relevant dossiers. It automatically signals developments in your chosen topics of interest. Apologies to unregistered users, we can no longer add new users.This service will discontinue in the near future.